All adults should receive annual influenza vaccine⁽¹⁾⁽²⁾ with particular importance in individuals with a history of prior pneumonia, underlying structural lung disease, immunocompromise or chronic medical conditions.
If PPSV‐23⁽²⁾ is given first, a year should elapse before giving PCV‐13⁽²⁾⁽³⁾ for those who are candidates for dual vaccination.
If prior history of pneumococcal vaccine is not known and a patient qualifies, vaccination should be provided with documentation of this administration.
Depending on risk group, patients should receive either single or dual vaccination (see below).
(1) Live attenuated vaccine
(2) Inactive or component vaccine
(3) Only covered by MSP for certain indications
PPSV‐23: 23 valent pneumococcal polysaccharide vaccine
PCV‐13: 13 valent pneumococcal conjugate vaccine